Antiplatelet therapy: new pharmacological agents and changing paradigms
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiplatelet therapy: new pharmacological agents and changing paradigms
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 11, Issue -, Pages 316-329
Publisher
Wiley
Online
2013-07-01
DOI
10.1111/jth.12219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study
- (2013) Payal Kohli et al. CIRCULATION
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
- (2013) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Vorapaxar in Patients With Prior Ischemic Stroke
- (2013) David A. Morrow et al. STROKE
- Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2012) Jan H. Cornel et al. AMERICAN HEART JOURNAL
- Reduced immediate ischemic events with cangrelor in PCI: A pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction
- (2012) Harvey D. White et al. AMERICAN HEART JOURNAL
- A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y 12 Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention
- (2012) Robert C. Welsh et al. Circulation-Cardiovascular Interventions
- New Directions in Antiplatelet Therapy
- (2012) José Luis Ferreiro et al. Circulation-Cardiovascular Interventions
- Pharmacokinetic and Pharmacodynamic Effects of Elinogrel
- (2012) Dominick J. Angiolillo et al. Circulation-Cardiovascular Interventions
- Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes
- (2012) Steen Husted et al.
- New Perspectives in Antiplatelet Therapy
- (2012) A. Tello-Montoliu et al. CURRENT MEDICINAL CHEMISTRY
- The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes
- (2012) Dominick J. Angiolillo DRUGS
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
- (2012) Dominick J. Angiolillo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort
- (2012) Peter K. Smith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease
- (2012) Matthew J. Price et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients
- (2012) David Erlinge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
- (2012) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials
- (2012) D. CAPODANNO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation
- (2012) José L. Ferreiro et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
- (2012) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers
- (2012) Antonio Tello-Montoliu et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
- (2012) Benjamin M Scirica et al. LANCET
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease
- (2012) Fabiana Rollini et al. PLATELETS
- EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin
- (2012) Kjell S. Sakariassen et al. THROMBOSIS RESEARCH
- Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies
- (2011) Stephen D. Wiviott et al. AMERICAN JOURNAL OF CARDIOLOGY
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
- (2011) Stephen D. Wiviott et al. CIRCULATION
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
- (2011) Michelle L. O'Donoghue et al. CIRCULATION
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2011) Kenneth W. Mahaffey et al. CIRCULATION
- 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
- (2011) et al. CIRCULATION
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) et al. CIRCULATION
- American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death
- (2011) Marc P. Bonaca et al. CIRCULATION
- Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans
- (2011) Daniel J Cushing et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Bleeding and Acute Coronary Syndromes: Defining, Predicting, and Managing Risk and Outcomes
- (2011) Sharif A. Halim et al. CURRENT DRUG TARGETS
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2011) R. C. Becker et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- Optimizing Platelet Inhibition in Clopidogrel Poor Metabolizers
- (2011) Dominick J. Angiolillo et al. JACC-Cardiovascular Interventions
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial
- (2011) Benjamin M. Scirica et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibición del receptor plaquetario P2Y12 de adenosina difosfato plaquetario: efectos beneficiosos y limitaciones de las estrategias terapéuticas actuales y perspectivas futuras
- (2011) Dominick J. Angiolillo et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
- (2010) Stefan James et al. CIRCULATION
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- Basic Principles of Platelet Biology and Clinical Implications
- (2010) Dominick J. Angiolillo et al. CIRCULATION JOURNAL
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
- (2010) et al. EUROPEAN HEART JOURNAL
- The Thromboxane/Endoperoxide Receptor (TP): The Common Villain
- (2010) Michel Félétou et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Integrated Analysis of Pharmacokinetic Data Across Multiple Clinical Pharmacology Studies of Prasugrel, a New Thienopyridine Antiplatelet Agent
- (2010) David S. Small et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes
- (2010) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
- (2010) Claes Held et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Prostanoid and TP-receptors in atherothrombosis: Is there a role for their antagonism?
- (2010) Chiara Giannarelli et al. THROMBOSIS AND HAEMOSTASIS
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Platelet thrombin receptor antagonism and atherothrombosis
- (2009) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacology of emerging novel platelet inhibitors
- (2008) Dominick J. Angiolillo et al. AMERICAN HEART JOURNAL
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
- (2008) S. A. Murphy et al. EUROPEAN HEART JOURNAL
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
- (2008) Elliott M. Antman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Role of Aspirin in Cardiovascular Prevention
- (2008) Armen Yuri Gasparyan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
- (2008) Stephen D Wiviott et al. LANCET
- Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect
- (2007) Steven R. Steinhubl et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More